Management of Atopic Dermatitis in Adults in Saudi Arabia: Consensus Recommendations from the Dermatological Expert Group

References

• Avena-Woods C. Overview of atopic dermatitis. Am J Manag Care. 2017;23:S115–S123.
   PubMed Web of Science ®Google Scholar
• Weidinger S, Beck LA, Bieber T, et al. Atopic dermatitis. Nat Rev Dis Primers. 2018;4:1. doi:10.1038/s41572-018-0001-z
   PubMed Web of Science ®Google Scholar
• Wollenberg A, Christen‐Zäch S, Taieb A, et al. ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children. J Eur Acad Dermatol Venerol. 2020;34:2717–2744. doi:10.1111/jdv.16892
   PubMed Web of Science ®Google Scholar
• Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet. 2020;396:345–360. doi:10.1016/S0140-6736(20)31286-1
   PubMed Web of Science ®Google Scholar
• Al-Afif KAM, Buraik MA, Buddenkotte J, et al. Understanding the burden of atopic dermatitis in Africa and the Middle East. Dermatol Ther. 2019;9:223–241. doi:10.1007/s13555-019-0285-2
   PubMed Web of Science ®Google Scholar
• Mohammad Y, Tabbah K, Mohammad S, et al. International study of asthma and allergies in childhood: Phase 3 in the Syrian Arab Republic. East Mediterr Health J. 2010;16:710–716. doi:10.26719/2010.16.7.710
   PubMedGoogle Scholar
• Rahimi Rad MH, Hejazi ME, Behrouzian R. Asthma and other allergic diseases in 13–14-year-old school children in Urmia, Iran. East Mediterr Health J. 2007;13:1005–1016. doi:10.26719/2007.13.5.1005
   PubMedGoogle Scholar
• Behbehani NA, Abal A, Syabbalo NC, et al. Prevalence of asthma, allergic rhinitis, and eczema in 13- to 14-year-old children in Kuwait: an ISAAC study. International study of asthma and allergies in childhood. Ann Allergy Asthma Immunol. 2000;85:58–63. doi:10.1016/S1081-1206(10)62435-0
   PubMed Web of Science ®Google Scholar
• Al-Riyami BM, Al-Rawas OA, Al-Riyami AA, et al. A relatively high prevalence and severity of asthma, allergic rhinitis and atopic eczema in school children in the Sultanate of Oman. Respirology. 2003;8:69–76. doi:10.1046/j.1440-1843.2003.00426.x
   PubMed Web of Science ®Google Scholar
• Reda AM, Elgendi A, Ebraheem AI, et al. A practical algorithm for topical treatment of atopic dermatitis in the Middle East emphasizing the importance of sensitive skin areas. J Dermatolog Treat. 2019;30:366–373. doi:10.1080/09546634.2018.1524823
   PubMed Web of Science ®Google Scholar
• Sabry EY. Prevalence of allergic diseases in a sample of Taif citizens assessed by an original Arabic questionnaire (phase I): a pioneer study in Saudi Arabia. Allergol Immunopathol. 2011;39:96–105. doi:10.1016/j.aller.2010.05.009
   PubMed Web of Science ®Google Scholar
• Cho YT, Chu CY. Advances in systemic treatment for adults with moderate-to-severe atopic dermatitis. Dermatol Sin. 2019;37:3–11. doi:10.4103/ds.ds_48_18
   Web of Science ®Google Scholar
• Weidinger S, Natalija N. Atopic dermatitis. Lancet. 2016;387:1109–1122. doi:10.1016/S0140-6736(15)00149-X
   PubMed Web of Science ®Google Scholar
• Imai Y, Yasuda K, Sakaguchi Y, et al. Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice. Proc Natl Acad Sci USA. 2013;110:13921–13926. doi:10.1073/pnas.1307321110
   PubMed Web of Science ®Google Scholar
• Salimi M, Barlow JL, Saunders SP, et al. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med. 2013;210:2939–2950. doi:10.1084/jem.20130351
   PubMed Web of Science ®Google Scholar
• Rudzki E, Samochocki Z, Rebandel P, et al. Frequency and significance of the major and minor features of Hanifin and Rajka among patients with atopic dermatitis. Dermatology. 1994;189:41–46. doi:10.1159/000246781
   PubMed Web of Science ®Google Scholar
• Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70:338–351. doi:10.1016/j.jaad.2013.10.010
   PubMed Web of Science ®Google Scholar
• Gooderham MJ, Bissonnette R, Grewal P, et al. Approach to the assessment and management of adult patients with atopic dermatitis: a consensus document. Section II: tools for assessing the severity of atopic dermatitis. J Cutan Med Surg. 2018;22:10S–16S. doi:10.1177/1203475418803628
   PubMed Web of Science ®Google Scholar
• Eichenfield LF, Ahluwalia J, Waldman A, et al. Current guidelines for the evaluation and management of atopic dermatitis: a comparison of the joint task force practice parameter and American Academy of Dermatology guidelines. J Allergy Clin Immunol. 2017;139:S49–S57. doi:10.1016/j.jaci.2017.01.009
   PubMed Web of Science ®Google Scholar
• Ring J, Alomar A, Bieber T, et al. Guidelines for treatment of atopic eczema (atopic dermatitis) Part II. J Eur Acad Dermatol Venereol. 2012;26:1176–1193. doi:10.1111/j.1468-3083.2012.04636.x
   PubMed Web of Science ®Google Scholar
• Rubel D, Thirumoorthy T, Soebaryo RW, et al. Consensus guidelines for the management of atopic dermatitis: an Asia-Pacific perspective. J Dermatol. 2013;40:160–171. doi:10.1111/1346-8138.12065
   PubMed Web of Science ®Google Scholar
• Chopra R, Silverberg JI. Assessing the severity of atopic dermatitis in clinical trials and practice. Clin Dermatol. 2018;36:606–615. doi:10.1016/j.clindermatol.2018.05.012
   PubMed Web of Science ®Google Scholar
• Simpson E, Eckert L, Gadkari A, et al. Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis. BMC Dermatol. 2019;19:15. doi:10.1186/s12895-019-0095-3
   PubMed Web of Science ®Google Scholar
• Pariser DM, Simpson EL, Gadkari A, et al. Evaluating patient-perceived control of atopic dermatitis: design, validation, and scoring of the Atopic Dermatitis Control Tool (ADCT). Curr Med Res Opin. 2020;36:367–376. doi:10.1080/03007995.2019.1699516
   PubMed Web of Science ®Google Scholar
• Megna M, Napolitano M, Patruno C, et al. Systemic treatment of adult atopic dermatitis: a Review. Dermatol Ther. 2017;7:1–23. doi:10.1007/s13555-016-0170-1
   PubMed Web of Science ®Google Scholar
• Deleuran M, Thaçi D, Beck LA, et al. Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study. J Am Acad Dermatol. 2020;82:377–388. doi:10.1016/j.jaad.2019.07.074
   PubMed Web of Science ®Google Scholar